Cyrus Biotechnology
Cyrus Biotechnology develops computationally engineered biologics from natural proteins for therapeutic applications, with lead programs targeting severe autoimmune diseases and acute respiratory distress syndrome. The company uses protein design algorithms and laboratory methods to create novel variants and fusion proteins, aiming to provide superior efficacy and address unmet medical needs.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2014
- Type
- Corporation Seattle business license
- Employees
- 17
- Registered name
- Cyrus Biotechnology Inc Seattle business license
- Stage
- Series B
- Members see funding amounts. .
- Founders
- David Baker
Is this your organization? Claim it
Founders
-
Lucas Nivon Executive Officer, Director, Co-Founder and Chief Executive Officer
-
Yifan Song Director, Co-founder and Chief Technology Officer
Executives
-
Erik Procko Executive, Chief Scientific Officer